Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin Hahn

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Neurological Research and Practice|September 12, 2025
Real-world treatment management in hereditary transthyretin amyloidosis - an experience report and proposal for therapy switch decision criteriaDuc Chu Dieu, Helena F Pernice, Harisa Muratovic, et al.
World Journal of Diabetes|January 15, 2024
Acupuncture in diabetic peripheral neuropathy-neurological outcomes of the randomized acupuncture in diabetic peripheral neuropathy trialSebastian Hoerder, Isabel Valentina Habermann, Katrin Hahn, et al.
Journal of Neuropathology and Experimental Neurology|January 29, 2022
Progressive Hereditary Transthyretin-Related Amyloidosis (ATTRv) Aggravated by ATTR Wild-Type and Complement ActivationIsabel Mattig, Bettina Heidecker, Carsten Tschöpe, et al.
Cardiology and Therapy|May 24, 2025
Correction: Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis CareJulian D Gillmore, Katrin Hahn, J Gustav Smith, et al.
Digital Health|February 24, 2026
ePA4all-Exploring facilitators and barriers to the adoption of the electronic health record in Germany: A study protocol for a mixed-methods analysisSusann May, Felix Muehlensiepen, Gina Barzen, et al.
Cardiology and Therapy|March 20, 2025
Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis CareJulian D Gillmore, Katrin Hahn, J Gustav Smith, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 26, 2006
Granzyme B mediates neurotoxicity through a G-protein-coupled receptorTongguang Wang, Rameeza Allie, Katherine Conant, et al.
Journal of Neurology|August 28, 2023
Cortical somatosensory evoked potential amplitudes and clinical outcome after cardiac arrest: a retrospective multicenter studyNoelle Aalberts, Erik Westhall, Birger Johnsen, et al.
Journal of Neurology|September 3, 2025
A new screening tool for early recognition of ATTRv polyneuropathy in clinical practice: AmyloScan<sup>®</sup>Juliane Sachau, Lena Rhode, Maike F Dohrn, et al.
International Journal of Cardiology|December 4, 2023
Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry diseaseIsabel Mattig, Tilman Steudel, Gina Barzen, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Neurological Research and Practice|September 12, 2025
Real-world treatment management in hereditary transthyretin amyloidosis - an experience report and proposal for therapy switch decision criteriaDuc Chu Dieu, Helena F Pernice, Harisa Muratovic, et al.
World Journal of Diabetes|January 15, 2024
Acupuncture in diabetic peripheral neuropathy-neurological outcomes of the randomized acupuncture in diabetic peripheral neuropathy trialSebastian Hoerder, Isabel Valentina Habermann, Katrin Hahn, et al.
Journal of Neuropathology and Experimental Neurology|January 29, 2022
Progressive Hereditary Transthyretin-Related Amyloidosis (ATTRv) Aggravated by ATTR Wild-Type and Complement ActivationIsabel Mattig, Bettina Heidecker, Carsten Tschöpe, et al.
Cardiology and Therapy|May 24, 2025
Correction: Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis CareJulian D Gillmore, Katrin Hahn, J Gustav Smith, et al.
Digital Health|February 24, 2026
ePA4all-Exploring facilitators and barriers to the adoption of the electronic health record in Germany: A study protocol for a mixed-methods analysisSusann May, Felix Muehlensiepen, Gina Barzen, et al.
Cardiology and Therapy|March 20, 2025
Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis CareJulian D Gillmore, Katrin Hahn, J Gustav Smith, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 26, 2006
Granzyme B mediates neurotoxicity through a G-protein-coupled receptorTongguang Wang, Rameeza Allie, Katherine Conant, et al.
Journal of Neurology|August 28, 2023
Cortical somatosensory evoked potential amplitudes and clinical outcome after cardiac arrest: a retrospective multicenter studyNoelle Aalberts, Erik Westhall, Birger Johnsen, et al.
Journal of Neurology|September 3, 2025
A new screening tool for early recognition of ATTRv polyneuropathy in clinical practice: AmyloScan<sup>®</sup>Juliane Sachau, Lena Rhode, Maike F Dohrn, et al.
International Journal of Cardiology|December 4, 2023
Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry diseaseIsabel Mattig, Tilman Steudel, Gina Barzen, et al.
Pageof 8